Title
Very Small Embryonic-like Stem Cells for Knee Osteoarthritis
Autologous Very Small Embryonic-like Stem Cells(VSELs) for Knee Osteoarthritis
Phase
Phase 1/Phase 2Lead Sponsor
Jinan UniversityStudy Type
InterventionalStatus
WithdrawnIndication/Condition
Stem Cell Transplant Complications Knee OsteoarthritisIntervention/Treatment
very small embryonic-like stem cellStudy Participants
0The aim of this study is the safety and efficacy of autologous very small embryonic-like stem cells(VSELs) to knee osteoarthritis.
VSELs come from the patient's peripheral blood, and will be injected in the most painful knee, or the worse knee on physical examination. Then follow-up the knee pain and imaging changes at 6 months and 1 year after treatment.
Mononuclear cells were collected from peripheral blood of each patient using a machine, VSELs were isolated, and each group was injected according to different numbers after activation
A mean volume of 5.5 mL platelet-rich plasma containing approximately 120,000 cells were prepared and injected into the selected knee of the patient
A mean volume of 5.5 mL platelet-rich plasma containing approximately 90,000 cells were prepared and injected into the selected knee of the patient
A mean volume of 5.5 mL platelet-rich plasma containing approximately 60,000 cells were prepared and injected into the selected knee of the patient
A mean volume of 5.5 mL platelet-rich plasma containing no VSELs injected into the selected knee of the patient
Inclusion Criteria: Patients had moderate to severe osteoarthritis of both knees. Those had mechanical pain of knee joints, which was aggravated by walking or stair climbing. Those complained of gelling pain of knee joint. Those have crepitus and limitation of the joint range of motion with joint bony hypertrophy on physical examination, X-rays showed narrowing of joint space and osteophyte formation Exclusion Criteria: Diabetic foot and patients with obvious edema in the legs caused by various causes Blood disease patients, thrombocytopenia or dysfunction, hypofibrinemia or anticoagulant therapy, long-term use of aspirin